logo
Sign In
Farxiga vs. GlyxambiBerinert vs. CinryzeEmgality vs. QuliptaFarxiga vs. InvokanaFirazyr vs. SajazirGlyxambi vs. InvokanaInvokamet vs. SynjardyOpzelura vs. DupixentOrencia vs. RinvoqQulipta vs. VyeptiStelara vs. TremfyaSynjardy vs. VictozaTaltz vs. BimzelxVyepti vs. Nurtec ODTView all Comparisons
ADHD drugsAnxiety drugsAsthma drugsAtopic dermatitis drugsDepression drugsHeart failure drugsHypertension drugsLymphoma drugsOsteoarthritis drugsRheumatoid arthritis drugsRosacea drugsSchizophrenia drugsType 2 Diabetes drugsView all Indications
Bayer drugsAbbVie drugsAstraZeneca drugsEli Lilly and Company drugsGenetech drugsGlaxoSmithKline (GSK) drugsNovartis drugsPfizer drugsTakeda Pharmaceuticals drugsTeva Pharmaceuticals drugsAmgen drugsView all Manufacturers
Beta-Adrenergic BlockerAngiotensin Converting Enzyme InhibitorAngiotensin 2 Receptor BlockerCalcium Channel BlockerDiureticsHMG-CoA Reductase InhibitorProton Pump InhibitorSelective Serotonin Reuptake InhibitorNorepinephrine Reuptake InhibitorBenzodiazepinesOpioid AgonistsNonsteroidal Anti-inflammatory DrugsAntiepileptic AgentsAntipsychoticsAntihistaminesView all Classes
Wegovy®Ozempic®Mounjaro®Zepbound®Jardiance®Farxiga®Dupixent®Trulicity®Lyrica®Lipitor®Effexor®Concerta®Depakote®Trintellix®Rexulti®Rinvoq®Verzenio®Taltz®
For ProvidersRequest DemoJoin Research Panel
For BusinessHCP ChannelCommercial O/SEngageMarketplaceOneHubInsight
Tools & MorePrescribing InfoCoverageSavingsPatient ResourcesA-Z IndicationsCompare Drugs
CompanyAboutInsightsCareersContactSecurity
Legit Script Certified
Get the latest insights in your inbox
Follow us
Legit Script Certified
  • Terms and Conditions
  • Privacy Policy
  • © 2025 PrescriberPoint. All Rights Reserved.

    • Medications for Acute Otitis Media

    FiltersReset Filters
    4 results

    • amoxicillin and clavulanate potassium

      (Amoxicillin and Clavulanate Potassium)
      Teva Pharmaceuticals USA, Inc.
      Usage: Amoxicillin and clavulanate potassium for oral suspension is indicated for children aged 3 months to 12 years (≤40 kg) with recurrent or persistent acute otitis media caused by susceptible strains of S. pneumoniae, H. influenzae, or M. catarrhalis, especially with specific risk factors.

    • azithromycin

      (Azithromycin)
      Bionpharma Inc.
      Usage: Azithromycin tablets are indicated for treating mild to moderate infections from susceptible bacteria, including acute bacterial exacerbations of chronic bronchitis, sinusitis, community-acquired pneumonia, pharyngitis/tonsillitis, uncomplicated skin infections, urethritis/cervicitis, and genital ulcer disease. Dosages vary between adults and pediatric patients.

    • azithromycin dihydrate

      (Azithromycin Dihydrate)
      Precision Dose, Inc.
      Usage: Azithromycin is indicated for treating mild to moderate infections, including bacterial exacerbations of chronic bronchitis, sinusitis, community-acquired pneumonia, pharyngitis, skin infections, and certain sexually transmitted infections, in both adult and pediatric patients. It should be used judiciously to minimize drug resistance.

    • azithromycin dihydrate

      (Azithromycin dihydrate)
      Precision Dose, Inc.
      Usage: Azithromycin is indicated for mild to moderate infections including acute bacterial exacerbations of chronic bronchitis, sinusitis, community-acquired pneumonia, pharyngitis/tonsillitis, uncomplicated skin infections, urethritis, cervicitis, and genital ulcer disease in men. It is also approved for pediatric conditions such as acute otitis media and pneumonia.